Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

63.60
-0.1300-0.20%
Post-market: 63.600.00000.00%19:39 EDT
Volume:9.45M
Turnover:602.09M
Market Cap:129.47B
PE:14.00
High:64.39
Open:64.07
Low:63.22
Close:63.73
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.28
T/O Rate:0.47%
Dividend:2.51
Dividend Rate:3.95%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.80
PE(LYR):18.38

Loading ...

CytomX Q2 Revenue Misses, Partly Hurt by Lower Research Activities in the Astellas Collaboration

Reuters
·
Aug 07

Prothena Publishes Corporate Overview Presentation on Protein-Dysregulation Drug Pipeline

Reuters
·
Aug 07

US FDA Approves Replimune's Skin Cancer Drug

Reuters
·
Aug 07

Prothena: May Earn $55 Mln Clinical Milestone Payment if Bristol Myers Squibb Decides to Advance Prx019 ; Bms Decision Expected Year End 2026

THOMSON REUTERS
·
Aug 07

Deal or no Deal, AstraZeneca Stock is a Bargain

Dow Jones
·
Aug 06

Bristol Myers Squibb (BMY) Stock Looks Reasonable Below Fair Value

Simply Wall St.
·
Aug 06

Bristol-Myers Squibb (BMY) Gets a Hold from RBC Capital

TIPRANKS
·
Aug 06

FTSE 100 Rises, Led by Glencore, Next Earnings; Banks Slide

Reuters
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

Movement Alert|Bristol-Myers Squibb Falls 3.19% in Regular Trading, Insiders Deny AstraZeneca Merger Talks

Market Focus
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

Schrodinger Signs Strategic Collaboration, Software Agreement with Bristol Myers Squibb for Bunsen AI Co-Scientist Deployment

Reuters
·
Aug 05

Bristol Myers Shares Down 2% Premarket After Reuters Reports 'No Discussions' over AstraZeneca Deal

THOMSON REUTERS
·
Aug 05

Movement Alert|Bristol-Myers Squibb Falls 3.14% in Pre-Market Trading, Trading at $64.2

Market Focus
·
Aug 05

Argus Upgrades Bristol-Myers Squibb to Buy From Hold, Price Target is $75

MT Newswires Live
·
Aug 05

Exclusive-'Never was a Deal to be Done' Between AstraZeneca and Bristol Myers Squibb, Senior Source Close to Matter Says

THOMSON REUTERS
·
Aug 05

Bristol-Myers Squibb Company : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05